...
首页> 外文期刊>Gut Pathogens >Effect of antimicrobial growth promoter administration on the intestinal microbiota of beef cattle
【24h】

Effect of antimicrobial growth promoter administration on the intestinal microbiota of beef cattle

机译:抗菌生长促进剂对肉牛肠道菌群的影响

获取原文
           

摘要

Background Antimicrobial growth promoters (AGPs) are antimicrobial agents administered to livestock in feed for prolonged periods to enhance feed efficiency. Beef cattle are primarily finished in confined feeding operations in Canada and the USA, and the administration of AGPs such as chlortetracycline and sulfamethazine (Aureo S-700 G) is the standard. The impacts of AGPs on the intestinal microbiota of beef cattle are currently uncertain; it is documented that AGPs administered to beef cattle pass through the rumen and enter the intestine. To ascertain the impacts of Aureo S-700 G on the small and large intestinal microbiota of beef cattle (mucosa-associated and within digesta), terminal restriction fragment length polymorphism (T-RFLP) analysis and quantitative PCR (qPCR) for total bacteria were applied. Beef cattle were maintained in an experimental feedlot (five replicate pens per treatment), and AGP treatment cattle were administered Aureo S-700 G in feed, whereas control cattle were administered no antimicrobials. As the intestinal microbiota of beef cattle has not been extensively examined, clone library analysis was applied to ascertain the primary bacterial constituents of the intestinal microbiota. Results Comparative T-RFLP and qPCR analysis (n?=?122 samples) revealed that bacterial community fingerprints and bacterial load within digesta differed from those associated with mucosa. However, the administration of Aureo S-700 G did not affect bacterial community fingerprints or bacterial load within the small and large intestine relative to control cattle. Analysis of >1500 near full length 16S rDNA clones revealed considerably greater bacterial diversity in the large relative to the small intestine of beef cattle. Mucosa-associated bacterial communities in the jejunum were dominated by Proteobacteria, and differed conspicuously from those in the ileum and large intestine. Although the ileum contained bacterial clones that were common to the jejunum as well as the cecum, Firmicutes clones associated with mucosa dominated in the ileum, cecum, and descending colon. In the descending colon, clone library analysis did not reveal a difference in the richness or diversity of bacterial communities within digesta relative to those associated with mucosa. However, T-RFLP analysis indicated a significant difference in T-RF relative abundance (i.e. difference in relative taxon abundance) between mucosa-associated and digesta communities attributed in part to the differential abundance of Bacteriodes, Alistipes, Oscillibacter, and unclassified Clostridiales. Conclusions These data demonstrate that there was no significant difference in the composition of the predominant intestinal bacteria constituents within animals administered Aureo S-700 G and those not administered AGPs after a 28 day withdrawal period.
机译:背景技术抗菌生长促进剂(AGP)是长期用于饲料中牲畜的抗菌剂,以提高饲料效率。肉牛主要在加拿大和美国的密闭饲喂操作中完成,并且标准的AGP(如金霉素和磺胺二甲嘧啶(Aureo S-700 G))的管理。目前尚不确定AGP对肉牛肠道菌群的影响。据记录,施用于肉牛的AGP通过瘤胃进入肠道。为了确定Aureo S-700 G对肉牛小肠和大肠微生物群(粘膜相关的和消化内的)的影响,对总细菌进行了最终限制性片段长度多态性(T-RFLP)分析和定量PCR(qPCR)应用。将牛肉牛饲养在实验饲养场中(每次处理五支重复笔),对AGP处理的牛饲喂Aureo S-700 G,而对对照的牛则不使用抗菌剂。由于尚未对肉牛的肠道菌群进行广泛检查,因此使用克隆文库分析来确定肠道菌群的主要细菌成分。结果比较T-RFLP和qPCR分析(n≥122个样品)表明,食糜中的细菌群落指纹和细菌载量与粘膜相关。但是,相对于对照牛,Aureo S-700 G的使用不会影响细菌群落指纹或小肠和大肠内的细菌负荷。对> 1500个近乎完整的16S rDNA克隆的分析显示,相对于肉牛的小肠而言,大细菌的多样性要大得多。空肠中与粘膜相关的细菌群落以变形杆菌为主导,并且与回肠和大肠中的明显不同。尽管回肠包含空肠和盲肠常见的细菌克隆,但与粘膜相关的沙门氏菌克隆在回肠,盲肠和降结肠中占主导地位。在降结肠中,克隆文库分析没有揭示消化物中细菌群落的丰富度或多样性相对于与粘膜相关的细菌群落的差异。然而,T-RFLP分析表明,与粘膜相关和消化的群落之间T-RF相对丰度(即相对分类群丰度)存在显着差异,部分归因于细菌,拟南芥,锁骨杆菌和未分类梭菌的丰度差异。结论这些数据表明,在停药28天后,施用Aureo S-700 G的动物和未施用AGP的动物中主要肠道细菌成分的组成没有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号